Drug Trial Radar · NCT05787574
A Study of Treatment of Inflammation Before Stem Cell Transplant in People With a Primary Immune Regulatory Disorder (PIRD) and/or an Autoinflammatory Condition
Last checked: Nov 20, 2026Latest source record: Jun 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
39
Planned (sponsor's estimate)
Start
Mar 15, 2023
Primary completion
Mar 2027
Study completion Mar 2027
Sponsor
- Lead sponsor
- Joseph OvedAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Sobi, Inc.
- First posted
- Mar 28, 2023
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The researchers are doing this study to find out whether emapalumab or a combination of fludarabine and dexamethasone are effective in preparing people with a primary immune regulatory disorder (PIRD) and/or an autoinflammatory condition to receive a stem cell transplant. The researchers will look at how well the study treatments reduce inflammation and aid in the engraftment process (the process of donated stem cells traveling to the bone marrow, where they begin to make new immune cells. "Funding Source - FDA OOPD"
Conditions
- Primary Immune Regulatory Disorder
- Autoimmune Lymphoproliferative
- Immune System Diseases
Interventions
EmapalumabDrug
Emapalumab on Days -22 (22 days before the day of the stem cell transplant), -15, -8, and -1.
Fludarabine and DexamethasoneDrug
Fludarabine and dexamethasone for 5 days in a row on Days -22 through -18.
Allogeneic hematopoietic stem cell transplant (allo-HCT)Procedure
Participants in both groups will receive their standard-of-care stem cell transplant on Day 0.
Primary outcomes
What the sponsor says the trial is designed to measure.
- EngraftmentTime frame: Day 100 post-alloHCT
Locations
13 sites in 1 country. Site status is shown where the registry gives one.
University of California, San Francisco
San Francisco, California · Recruiting
Children's Healthcare of Atlanta
Atlanta, Georgia · Recruiting
Memorial Sloan Kettering Basking Ridge
Basking Ridge, New Jersey · Active not recruiting
Memorial Sloan Kettering Monmouth
Middletown, New Jersey · Active not recruiting
Memorial Sloan Kettering Bergen
Montvale, New Jersey · Active not recruiting
Memorial Sloan Kettering Suffolk - Commack
Commack, New York · Active not recruiting
Memorial Sloan Kettering Westchester
Harrison, New York · Active not recruiting
Columbia University Irving Medical Center
New York, New York · Recruiting
Memorial Sloan Kettering Cancer Center
New York, New York · Active not recruiting
Memorial Sloan Kettering Nassau
Rockville Centre, New York · Active not recruiting
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania · Recruiting
Texas Children's Hospital
Houston, Texas · Recruiting
Children's Hospital of Wisconsin
Milwaukee, Wisconsin · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.